Quantifying the effect of seed orientation in postplanning dosimetry of low-dose-rate prostate brachytherapy

Medical Physics

Volumn 41, Issue 10, 2014, Pages

  Collins Fekete, Charles Antoine ^a,b   Plamondon, Mathieu ^a,b   Martin, André Guy ^b   Vigneault, Éric ^b   Verhaegen, Frank ^c,d   Beaulieu, Luc ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b Université Laval   (Canada)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

LDR; Monte Carlo; prostate brachytherapy; seeds orientation; TG186; TG43

Indexed keywords

ONCOLOGY; RADIOTHERAPY; UROLOGY;

BRACHYTHERAPY; DOSE DISTRIBUTIONS; LDR; LOW-DOSE RATES; MONTE CARLO; PROSTATE BRACHYTHERAPY; PROSTATE IMPLANTS; SEED ORIENTATION; TG186; TG43;

DOSIMETRY;

IODINE 125;

ANISOTROPY; ARTICLE; BLADDER; BRACHYTHERAPY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; DIGITAL IMAGING AND COMMUNICATIONS IN MEDICINE; DOSE CALCULATION; DOSIMETRY; GEOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONTE CARLO METHOD; ORGANS AT RISK; PROSTATE BRACHYTHERAPY; PROSTATE CANCER; RADIATION DOSE DISTRIBUTION; RECTUM; URETHRA; ALGORITHM; AUTOMATED PATTERN RECOGNITION; CALIBRATION; COHORT ANALYSIS; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER SIMULATION; DEVICES; PROCEDURES; PROSTATIC NEOPLASMS; PROSTHESES AND ORTHOSES; RADIATION DOSE; RADIATION RESPONSE; RADIOMETRY;

ALGORITHMS; BRACHYTHERAPY; CALIBRATION; COHORT STUDIES; COMPUTER SIMULATION; HUMANS; MALE; MONTE CARLO METHOD; PATTERN RECOGNITION, AUTOMATED; PROSTATIC NEOPLASMS; PROSTHESES AND IMPLANTS; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED; URETHRA; URINARY BLADDER;

EID: 84907459436     PISSN: 00942405     EISSN: 24734209     Source Type: Journal    
DOI: 10.1118/1.4895012     Document Type: Article

References (43)

1. S. A. Enger et al., " Layered mass geometry: A novel technique to overlay seeds and applicators onto patient geometry in geant4 brachytherapy simulations," Phys. Med. Biol. 57 (19), 6269-6277 (2012). 10.1088/0031-9155/57/19/6269
2. B. J. Davis et al., " American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy," Brachytherapy 11 (1), 6-19 (2012). 10.1016/j.brachy.2011.07.005
3. R. Nath, L. L. Anderson, G. Luxton, K. A. Weaver, J. F. Williamson, and A. S. Meigooni, " Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine," Med. Phys. 22 (2), 209-234 (1995). 10.1118/1.597458
4. D. Ash, A. Flynn, J. Battermann, T. de Reijke, P. Lavagnini, and L. Blank, " ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer," Radiother. Oncol. 57 (3), 315-321 (2000). 10.1016/S0167-8140(00)00306-6
5. R. Nath et al., " AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: Report of Task Group 137," Med. Phys. 36 (11), 5310-5322 (2009). 10.1118/1.3246613
6. I. Ali et al., " A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy," Phys. Med. Biol. 54 (18), 5595-5611 (2009). 10.1088/0031-9155/54/18/016
7. N. Chng, I. Spadinger, R. Rasoda, W. J. Morris, and S. Salcudean, " Prostate brachytherapy postimplant dosimetry: Seed orientation and the impact of dosimetric anisotropy in stranded implants," Med. Phys. 39, 721-731 (2012). 10.1118/1.3671921
8. J. E. Dawson, T. Wu, T. Roy, J. Y. Gu, and H. Kim, " Dose effects of seeds placement deviations from pre-planned positions in ultrasound guided prostate implants," Radiother. Oncol. 32 (3), 268-270 (1994). 10.1016/0167-8140(94)90027-2
9. A. K. H. Robertson, P. S. Basran, S. D. Thomas, and D. Wells, " CT, MR, and ultrasound image artifacts from prostate brachytherapy seed implants: The impact of seed size," Med. Phys. 39 (4), 2061-2068 (2012). 10.1118/1.3694669
10. 125I permanent seed implants over a wide range of seed number, activity, and designs," Int. J. Radiat. Oncol., Biol., Phys. 58 (4), 1298-1308 (2004). 10.1016/j.ijrobp.2003.11.016
11. G. Wan, Z. Wei, L. Gardi, D. B. Downey, and A. Fenster, " Brachytherapy needle deflection evaluation and correction," Med. Phys. 32 (4), 902-909 (2005). 10.1118/1.1871372
12. D. Tubic, A. Zaccarin, J. Pouliot, and L. Beaulieu, " Automated seed detection and three-dimensional reconstruction. I. Seed localization from fluoroscopic images or radiographs," Med. Phys. 28 (11), 2265-2271 (2001). 10.1118/1.1414308
13. Ibid., " Automated seed detection and three-dimensional reconstruction. II. Reconstruction of permanent prostate implants using simulated annealing," Med. Phys. 28 (11), 2272-2279 (2001). 10.1118/1.1414309
14. 125I prostate implants," Radiother. Oncol. 72 (2), 213-220 (2004). 10.1016/j.radonc.2004.04.001
15. 125I prostate implants," Australas. Phys. Eng. Sci. Med. 20 (2), 57-63 (1997).
16. 125I prostate implants," Med. Phys. 32 (8), 2557-2566 (2005). 10.1118/1.1897466
17. 103Pd," Med. Phys. 28 (3), 336-345 (2001). 10.1118/1.1350674
18. S. Nath, Z. Chen, N. Yue, S. Trumpore, and R. Peschel, " Dosimetric effects of needle divergence in prostate seed implant using I and Pd radioactive seeds," Med. Phys. 27, 1058-1066 (2000). 10.1118/1.598971
19. 125I prostate implants," Phys. Med. Biol. 46 (11), 2785-2800 (2001). 10.1088/0031-9155/46/11/303
20. S. Nag, W. Bice, K. DeWyngaert, B. Prestidge, R. Stock, and Y. Yu, " The american brachytherapy society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis," Int. J. Radiat. Oncol. 46 (1), 221-230 (2000). 10.1016/S0360-3016(99)00351-X
21. M. De Brabandere, P. Hoskin, K. Haustermans, F. Van den Heuvel, and F.-A. Siebert, " Prostate post-implant dosimetry: Interobserver variability in seed localisation, contouring and fusion," Radiother. Oncol. 104 (2), 192-198 (2012). 10.1016/j.radonc.2012.06.014
22. L. Beaulieu et al., " Report of the Task Group 186 on model-based dose calculation methods in brachytherapy beyond the TG-43 formalism: Current status and recommendations for clinical implementation," Med. Phys. 39 (10), 6208-6236 (2012). 10.1118/1.4747264
23. ICRP, " Report of the task group on reference man ICRP Publication 23 (1975)," in Annals of the ICRP (Pergamon, Oxford, 1980), Vol. 4(3-4), Part III.
24. International Commission on Radiation Units & Measurements, " Photon, electron, proton and neutron interaction data for body tissues," ICRU Report No. 46 (ICRU, Bethesda, MD, 1992).
25. M. J. Rivard et al., " Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations," Med. Phys. 31 (3), 633-674 (2004). 10.1118/1.1646040
26. 125I interstitial brachytherapy seed," Med. Phys. 28 (8), 1753-1760 (2001). 10.1118/1.1384460
27. 125I brachytherapy seed," Med. Phys. 33 (12), 4675-4684 (2006). 10.1118/1.2388158
28. 125I source," Med. Phys. 29 (6), 1029-1034 (2002). 10.1118/1.1478559
29. J. F. Williamson, " Monte Carlo evaluation of kerma at a point for photon transport problems," Med. Phys. 14 (4), 567-576 (1987). 10.1118/1.596069
30. US Department of Commerce, NIST: X-Ray Mass Attenuation Coefficients (2004).
31. H. Afsharpour et al., " ALGEBRA: ALgorithm for the heterogeneous dosimetry based on geant4 for BRAchytherapy," Phys. Med. Biol. 57 (11), 3273-3280 (2012). 10.1088/0031-9155/57/11/3273
32. 125I interstitial brachytherapy seed," Med. Phys. 33 (5), 1522-1523 (2006). 10.1118/1.2192909
33. H. Afsharpour, M. D'Amours, B. Cote, J.-F. Carrier, F. Verhaegen, and L. Beaulieu, " A Monte Carlo study on the effect of seed design on the interseed attenuation in permanent prostate implants," Med. Phys. 35 (8), 3671-3681 (2008). 10.1118/1.2955754
34. S. Agostinelli et al., " geant4-A simulation toolkit," Nucl. Instrum. Methods Phys. Res., Sect. A 506 (3), 250-303 (2003). 10.1016/S0168-9002(03)01368-8
35. C. Salembier et al., " Tumour and target volumes in permanent prostate brachytherapy: A supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy," Radiother. Oncol. 83 (1), 3-10 (2007). 10.1016/j.radonc.2007.01.014
36. D. H. I-Chow Hsu, " Dosimetric analysis of radiation therapy oncology group 0321: The importance of urethral dose," Pract. Radiat. Oncol. 4 (1), 27-34 (2014). 10.1016/j.prro.2013.02.011
37. J.-F. Carrier, L. Beaulieu, F. Therriault-Proulx, and R. Roy, " Impact of interseed attenuation and tissue composition for permanent prostate implants," Med. Phys. 33 (3), 595-604 (2006). 10.1118/1.2168295
38. J.-F. Carrier et al., " Postimplant dosimetry using a Monte Carlo Dose calculation engine: A new clinical standard," Int. J. Radiat. Oncol., Biol., Phys. 68 (4), 1190-1198 (2007). 10.1016/j.ijrobp.2007.02.036
39. A. Sampson, Y. Le, and J. F. Williamson, " Fast patient-specific Monte Carlo brachytherapy dose calculations via the correlated sampling variance reduction technique," Med. Phys. 39 (2), 1058-1068 (2012). 10.1118/1.3679018
40. G. Landry, B. Reniers, J.-P. Pignol, L. Beaulieu, and F. Verhaegen, " The difference of scoring dose to water or tissues in Monte Carlo dose calculations for low energy brachytherapy photon sources," Med. Phys. 38 (3), 1526-1533 (2011). 10.1118/1.3549760
41. M. J. Rivard, L. Beaulieu, and F. Mourtada, " Enhancements to commissioning techniques and quality assurance of brachytherapy treatment planning systems that use model-based dose calculation algorithms," Med. Phys. 37 (6), 2645-2658 (2010). 10.1118/1.3429131
42. 125I lung brachytherapy," Med. Phys. 39 (7), 4365-4377 (2012). 10.1118/1.4729737
43. I.-C. Hsu et al., " Phase II trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: Preliminary results of RTOG 0321," Int. J. Radiat. Oncol., Biol., Phys. 78 (3), 751-758 (2010). 10.1016/j.ijrobp.2009.08.048